AYUS concept
INUSpheresis®
Treatment fields
Media
Contact
International
Certified INUSpheresis®
Center Basel
The symptoms of both diseases can be significantly improved by reducing neurotransmitter receptor autoantibodies.
00/00
Summary of the study
Many patients infected with the SARS-CoV-2 virus complain of persistent shortness of breath and fatigue even months after the onset of the disease. This overwhelming phenomenon is not-well defined and has been termed "post-COVID syndrome" or "long-COVID".
This study examines the similarities with myalgic encephalomyelitis, also known as chronic fatigue syndrome, which is associated with viral and autoimmune pathogenesis. Neurotransmitter receptor antibodies to ß-adrenergic and muscarinic receptors may play a key role in both diseases.
The study found a similar increase in these autoantibodies in both groups of patients. Extracorporeal apheresis using a special filter appears to be effective in significantly reducing these antibodies and significantly improving the debilitating symptoms of patients with chronic fatigue syndrome.
Bornstein SR, Voit-Bak K, Donate T, Rodionov RN, Gainetdinov RR, Tselmin S, Kanczkowski W, Müller GM, Achleitner M, Wang J, Licinio J, Bauer M, Young AH, Thuret S, Bechmann N, Straube R. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Mol Psychiatry. 2022 Jan;27(1):34-37. doi: 10.1038/s41380-021-01148-4. epub 2021 Jun 17. PMID: 34140635; PMCID: PMC8209771.
00/00
Further studies in connection with INUSpheresis® therapy
00/00
Do you have any questions or need expert advice? We are here for you. Use our convenient online booking tool to make an appointment quickly or contact us by phone for a personal initial consultation.
Don't hesitate to contact us - your health is important to us!
